A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.

about

A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.

Item

http://www.wikidata.org/entity/Q45248410

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

A phase I study of intravenous ...... atients with multiple myeloma.

@en

A phase I study of intravenous ...... atients with multiple myeloma.

@nl

type

Item

label

A phase I study of intravenous ...... atients with multiple myeloma.

@en

A phase I study of intravenous ...... atients with multiple myeloma.

@nl

prefLabel

A phase I study of intravenous ...... atients with multiple myeloma.

@en

A phase I study of intravenous ...... atients with multiple myeloma.

@nl

P1476

A phase I study of intravenous ...... atients with multiple myeloma.

@en

P2093

Amrita Y Krishnan

http://www.w3.org/2001/XMLSchema#string

Joycelynne M Palmer

http://www.w3.org/2001/XMLSchema#string

Len Farol

http://www.w3.org/2001/XMLSchema#string

Myo Htut

http://www.w3.org/2001/XMLSchema#string

Ni-Chun Tsai

http://www.w3.org/2001/XMLSchema#string

Sandra H Thomas

http://www.w3.org/2001/XMLSchema#string

Shirong Wang

http://www.w3.org/2001/XMLSchema#string

Stephen J Forman

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.

P304

201-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2013.794268

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23573824

http://www.w3.org/2001/XMLSchema#string